ENDOMETRIAL CARCINOMA (EC)

Clinical trials for ENDOMETRIAL CARCINOMA (EC) explained in plain language.

Never miss a new study

Get alerted when new ENDOMETRIAL CARCINOMA (EC) trials appear

Sign up with your email to follow new studies for ENDOMETRIAL CARCINOMA (EC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 2

New hope for tough cancers: trial tests drug for patients out of options

Disease control Recruiting now

This study is testing a new drug called GV20-0251 for adults with advanced solid tumor cancers that have progressed despite standard treatments. The first part aims to find a safe dose, and the second part will see how well the drug works against several types of cancer, includin…

Matched conditions: ENDOMETRIAL CARCINOMA (EC)

Phase: PHASE1, PHASE2 • Sponsor: GV20 Therapeutics • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

ENDOMETRIAL CARCINOMA (EC)

Get alerted when new ENDOMETRIAL CARCINOMA (EC) trials appear

New hope for tough cancers: trial tests drug for patients out of options